News & AnalysisSynthego attracts $100m Series DSynthego, the genome engineering company, has raised $100 million in Series D financing.ByIris Dorbian27 August 2020•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareBriefs